nach oben

Erschienen in:

27.03.2019 | Original Contribution

A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apc^am1137)

verfasst von: Michele Navarra, Angelo Pietro Femia, Andrea Romagnoli, Katia Tortora, Cristina Luceri, Santa Cirmi, Nadia Ferlazzo, Giovanna Caderni

Erschienen in: European Journal of Nutrition | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the potential of a flavonoid-rich extract from bergamot juice (BJe) to prevent colorectal carcinogenesis (CRC) in vivo.

Main methods

Pirc rats (F344/NTac-Apc^am1137), mutated in Apc, the key gene in CRC, were treated with two different doses of BJe (35 mg/kg or 70 mg/kg body weight, respectively) mixed in the diet for 12 weeks. Then, the entire intestine was surgically removed and dissected for histological, immunohistochemical and molecular analyses.

Results

Rats treated with BJe showed a significant dose-related reduction in the colon preneoplastic lesions mucin-depleted foci (MDF). Colon and small intestinal tumours were also significantly reduced in rats supplemented with 70 mg/kg of BJe. To elucidate the involved mechanisms, markers of inflammation and apoptosis were determined. Compared to controls, colon tumours from BJe 70 mg/kg-supplemented rats showed a significant down-regulation of inflammation-related genes (COX-2, iNOS, IL-1β, IL-6 and IL-10 and Arginase 1). Moreover, in colon tumours from rats fed with 70 mg/kg BJe, apoptosis was significantly higher than in controls. Up-regulation of p53 and down-regulation of survivin and p21 genes was also observed.

Conclusions

These data indicate a strong chemopreventive activity of BJe that, at least in part, is due to its pro-apoptotic and anti-inflammatory actions. This effect could be exploited as a strategy to prevent CRC in high-risk patients.

Mannucci C, Navarra M, Calapai F, Squeri R, Gangemi S, Calapai G (2017) Clinical pharmacology of Citrus bergamia: a systematic review. Phytother Res 31(1):27–39. https://doi.org/10.1002/ptr.5734 CrossRefPubMed

Navarra M, Mannucci C, Delbo M, Calapai G (2015) Citrus bergamia essential oil: from basic research to clinical application. Front Pharmacol 6:36. https://doi.org/10.3389/fphar.2015.00036 CrossRefPubMedPubMedCentral

Navarra M, Ferlazzo N, Cirmi S, Trapasso E, Bramanti P, Lombardo GE, Minciullo PL, Calapai G, Gangemi S (2015) Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell growth. J Pharm Pharmacol 67(8):1042–1053. https://doi.org/10.1111/jphp.12403 CrossRefPubMed

Ferlazzo N, Cirmi S, Calapai G, Ventura-Spagnolo E, Gangemi S, Navarra M (2016) Anti-inflammatory activity of Citrus bergamia derivatives: where do we stand? Molecules. https://doi.org/10.3390/molecules21101273 CrossRefPubMedPubMedCentral

Delle Monache S, Sanita P, Trapasso E, Ursino MR, Dugo P, Russo M, Ferlazzo N, Calapai G, Angelucci A, Navarra M (2013) Mechanisms underlying the anti-tumoral effects of Citrus bergamia juice. PloS One 8(4):e61484. https://doi.org/10.1371/journal.pone.0061484 CrossRefPubMedPubMedCentral

Ferlazzo N, Cirmi S, Russo M, Trapasso E, Ursino MR, Lombardo GE, Gangemi S, Calapai G, Navarra M (2016) NF-kappaB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells. Life Sci 146:81–91. https://doi.org/10.1016/j.lfs.2015.12.040 CrossRefPubMed

Visalli G, Ferlazzo N, Cirmi S, Campiglia P, Gangemi S, Pietro AD, Calapai G, Navarra M (2014) Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells. Anticancer Agents Med Chem 14(10):1402–1413CrossRef

Navarra M, Ursino MR, Ferlazzo N, Russo M, Schumacher U, Valentiner U (2014) Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models. Fitoterapia 95:83–92. https://doi.org/10.1016/j.fitote.2014.02.009 CrossRefPubMed

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403. https://doi.org/10.1016/j.ejca.2012.12.027 CrossRefPubMed

10.

Li Y, Zhang T, Chen GY (2018) Flavonoids and colorectal cancer prevention. Antioxidants (Basel). https://doi.org/10.3390/antiox7120187 CrossRefPubMedCentral

11.

Cirmi S, Maugeri A, Ferlazzo N, Gangemi S, Calapai G, Schumacher U, Navarra M (2017) Anticancer potential of citrus juices and their extracts: a systematic review of both preclinical and clinical studies. Front Pharmacol 8:420. https://doi.org/10.3389/fphar.2017.00420 CrossRefPubMedPubMedCentral

12.

Cirmi S, Ferlazzo N, Lombardo GE, Maugeri A, Calapai G, Gangemi S, Navarra M (2016) Chemopreventive agents and inhibitors of cancer hallmarks: may citrus offer new perspectives? Nutrients. https://doi.org/10.3390/nu8110698 CrossRefPubMedPubMedCentral

13.

Cirmi S, Navarra M, Woodside JV, Cantwell MM (2018) Citrus fruits intake and oral cancer risk: a systematic review and meta-analysis. Pharmacol Res 133:187–194. https://doi.org/10.1016/j.phrs.2018.05.008 CrossRefPubMed

14.

Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, Weichert J, Haag JD, Chen KS, Waller JL, Gould MN, Dove WF (2007) A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci USA 104(10):4036–4041. https://doi.org/10.1073/pnas.0611690104 CrossRefPubMed

15.

Femia AP, Luceri C, Soares PV, Lodovici M, Caderni G (2015) Multiple mucin depleted foci, high proliferation and low apoptotic response in the onset of colon carcinogenesis of the PIRC rat, mutated in Apc. Int J Cancer 136(6):E488–E495. https://doi.org/10.1002/ijc.29232 CrossRefPubMed

16.

Ricciardiello L, Ahnen DJ, Lynch PM (2016) Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol 13(6):352–361. https://doi.org/10.1038/nrgastro.2016.56 CrossRefPubMed

17.

Ferlazzo N, Visalli G, Smeriglio A, Cirmi S, Lombardo GE, Campiglia P, Di Pietro A, Navarra M (2015) Flavonoid fraction of orange and bergamot juices protect human lung epithelial cells from hydrogen peroxide-induced oxidative stress. Evid Based Complement Altern Med 2015:957031. https://doi.org/10.1155/2015/957031 CrossRef

18.

Ferlazzo N, Visalli G, Cirmi S, Lombardo GE, Lagana P, Di Pietro A, Navarra M (2016) Natural iron chelators: protective role in A549 cells of flavonoids-rich extracts of citrus juices in Fe(3+)-induced oxidative stress. Environ Toxicol Pharmacol 43:248–256. https://doi.org/10.1016/j.etap.2016.03.005 CrossRefPubMed

19.

Curro M, Risitano R, Ferlazzo N, Cirmi S, Gangemi C, Caccamo D, Ientile R, Navarra M (2016) Citrus bergamia juice extract attenuates beta-amyloid-induced pro-inflammatory activation of THP-1 cells through MAPK and AP-1 pathways. Sci Rep 6:20809. https://doi.org/10.1038/srep20809 CrossRefPubMedPubMedCentral

20.

Impellizzeri D, Cordaro M, Campolo M, Gugliandolo E, Esposito E, Benedetto F, Cuzzocrea S, Navarra M (2016) Anti-inflammatory and antioxidant effects of flavonoid-rich fraction of bergamot juice (BJe) in a mouse model of intestinal ischemia/reperfusion Injury. Front Pharmacol 7:203. https://doi.org/10.3389/fphar.2016.00203 CrossRefPubMedPubMedCentral

21.

Impellizzeri D, Bruschetta G, Di Paola R, Ahmad A, Campolo M, Cuzzocrea S, Esposito E, Navarra M (2015) The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. Clin Nutr 34(6):1146–1154. https://doi.org/10.1016/j.clnu.2014.11.012 CrossRefPubMed

22.

Caderni G, De Filippo C, Luceri C, Salvadori M, Giannini A, Biggeri A, Remy S, Cheynier V, Dolara P (2000) Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 21(11):1965–1969CrossRef

23.

Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P (2003) Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 63(10):2388–2392PubMed

24.

Femia AP, Luceri C, Bianchini F, Salvadori M, Salvianti F, Pinzani P, Dolara P, Calorini L, Caderni G (2012) Marie Menard apples with high polyphenol content and a low-fat diet reduce 1,2-dimethylhydrazine-induced colon carcinogenesis in rats: effects on inflammation and apoptosis. Mol Nutr Food Res 56(8):1353–1357. https://doi.org/10.1002/mnfr.201200122 CrossRefPubMed

25.

Tortora K, Femia AP, Romagnoli A, Sineo I, Khatib M, Mulinacci N, Giovannelli L, Caderni G (2018) Pomegranate by-products in colorectal cancer chemoprevention: effects in Apc-mutated Pirc rats and mechanistic studies in vitro and ex vivo. Mol Nutr Food Res. https://doi.org/10.1002/mnfr.201700401 CrossRefPubMed

26.

Mager LF, Wasmer MH, Rau TT, Krebs P (2016) Cytokine-induced modulation of colorectal cancer. Front Oncol 6:96. https://doi.org/10.3389/fonc.2016.00096 CrossRefPubMedPubMedCentral

27.

Femia AP, Giannini A, Fazi M, Tarquini E, Salvadori M, Roncucci L, Tonelli F, Dolara P, Caderni G (2008) Identification of mucin depleted foci in the human colon. Cancer Prev Res 1(7):562–567. https://doi.org/10.1158/1940-6207.CAPR-08-0125 CrossRef

28.

Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G (2007) Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 67(2):445–449. https://doi.org/10.1158/0008-5472.CAN-06-3861 CrossRefPubMed

29.

Femia AP, Dolara P, Caderni G (2004) Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 25(2):277–281. https://doi.org/10.1093/carcin/bgh005 CrossRefPubMed

30.

Cirmi S, Ferlazzo N, Lombardo GE, Ventura-Spagnolo E, Gangemi S, Calapai G, Navarra M (2016) Neurodegenerative diseases: might citrus flavonoids play a protective role? Molecules. https://doi.org/10.3390/molecules21101312 CrossRefPubMedPubMedCentral

31.

Citraro R, Navarra M, Leo A, Donato Di Paola E, Santangelo E, Lippiello P, Aiello R, Russo E, De Sarro G (2016) The anticonvulsant activity of a flavonoid-rich extract from orange juice involves both NMDA and GABA-benzodiazepine receptor complexes. Molecules. https://doi.org/10.3390/molecules21091261 CrossRefPubMedPubMedCentral

32.

Cirmi S, Bisignano C, Mandalari G, Navarra M (2016) Anti-infective potential of Citrus bergamia Risso et Poiteau (bergamot) derivatives: a systematic review. Phytother Res 30(9):1404–1411. https://doi.org/10.1002/ptr.5646 CrossRefPubMed

33.

Celano M, Maggisano V, De Rose RF, Bulotta S, Maiuolo J, Navarra M, Russo D (2015) Flavonoid fraction of citrus reticulata juice reduces proliferation and migration of anaplastic thyroid carcinoma cells. Nutr Cancer 67(7):1183–1190. https://doi.org/10.1080/01635581.2015.1073760 CrossRefPubMed

34.

Fusco R, Cirmi S, Gugliandolo E, Di Paola R, Cuzzocrea S, Navarra M (2017) A flavonoid-rich extract of orange juice reduced oxidative stress in an experimental model of inflammatory bowel disease. J Funct Foods 30:168–178. https://doi.org/10.1016/j.jff.2016.12.038 CrossRef

35.

Filocamo A, Bisignano C, Ferlazzo N, Cirmi S, Mandalari G, Navarra M (2015) In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori. BMC Complement Altern Med 15:256. https://doi.org/10.1186/s12906-015-0769-2 CrossRefPubMedPubMedCentral

36.

Gugliandolo E, Fusco R, D’Amico R, Peditto M, Oteri G, Di Paola R, Cuzzocrea S, Navarra M (2018) Treatment with a flavonoid-rich fraction of bergamot juice improved lipopolysaccharide-induced periodontitis in rats. Front Pharmacol 9:1563. https://doi.org/10.3389/fphar.2018.01563 CrossRefPubMed

37.

Marino A, Paterniti I, Cordaro M, Morabito R, Campolo M, Navarra M, Cuzzocrea S (2015) Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis. PharmaNutrition 3(2):53–59. https://doi.org/10.1016/j.phanu.2015.03.002 CrossRef

38.

Pesic M, Greten FR (2016) Inflammation and cancer: tissue regeneration gone awry. Curr Opin Cell Biol 43:55–61. https://doi.org/10.1016/j.ceb.2016.07.010 CrossRefPubMed

39.

Femia AP, Dolara P, Luceri C, Salvadori M, Caderni G (2009) Mucin-depleted foci show strong activation of inflammatory markers in 1,2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate. Int J Cancer 125(3):541–547. https://doi.org/10.1002/ijc.24417 CrossRefPubMed

40.

Warren CA, Paulhill KJ, Davidson LA, Lupton JR, Taddeo SS, Hong MY, Carroll RJ, Chapkin RS, Turner ND (2009) Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J Nutr 139(1):101–105. https://doi.org/10.3945/jn.108.096271 CrossRefPubMedPubMedCentral

41.

Zhang F, Wang H, Wang X, Jiang G, Liu H, Zhang G, Wang H, Fang R, Bu X, Cai S, Du J (2016) TGF-beta induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget 7(32):52294–52306. https://doi.org/10.18632/oncotarget.10561 CrossRefPubMedPubMedCentral

42.

Kaler P, Augenlicht L, Klampfer L (2009) Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 28(44):3892–3902. https://doi.org/10.1038/onc.2009.247 CrossRefPubMedPubMedCentral

43.

Venkatachalam K, Gunasekaran S, Namasivayam N (2016) Biochemical and molecular mechanisms underlying the chemopreventive efficacy of rosmarinic acid in a rat colon cancer. Eur J Pharmacol 791:37–50. https://doi.org/10.1016/j.ejphar.2016.07.051 CrossRefPubMed

44.

Ravillah D, Mohammed A, Qian L, Brewer M, Zhang YT, Biddick L, Steele VE, Rao CV (2014) Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APC(min/+) mouse intestinal tumorigenesis. J Pharmacol Exp Ther 348(1):59–68. https://doi.org/10.1124/jpet.113.208645 CrossRefPubMedPubMedCentral

45.

Romanov VS, Pospelov VA, Pospelova TV (2012) Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Moscow) 77(6):575–584. https://doi.org/10.1134/S000629791206003x CrossRef

46.

Sun SY, Hail N Jr, Lotan R (2004) Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 96(9):662–672CrossRef

Titel: A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apcam1137)
verfasst von: Michele Navarra
Angelo Pietro Femia
Andrea Romagnoli
Katia Tortora
Cristina Luceri
Santa Cirmi
Nadia Ferlazzo
Giovanna Caderni
Publikationsdatum: 27.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 3/2020
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-019-01948-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apc^am1137)

Abstract

Purpose

Main methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Main methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols

Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto’s thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies

Is high oily fish intake achievable and how does it affect nutrient status in 8–9-year-old children?: the FiSK Junior trial

High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam

Mediterranean diet, physical activity and subcutaneous advanced glycation end-products’ accumulation: a cross-sectional analysis in the ILERVAS project

Plasma concentrations and ACE-inhibitory effects of tryptophan-containing peptides from whey protein hydrolysate in healthy volunteers

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin